Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea

Lignende værker

• Erratum: Addition of Author's Affiliated Institute and Correction of the Author's Name. Corrected: Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea
  af: Baik, Yeong Ok, et al.
  Udgivet: (2014)
• Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
  af: Lee, Eun Young, et al.
  Udgivet: (2018)
• A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia
  af: Desai, Sachin N., et al.
  Udgivet: (2015)
• Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
  af: Trach, D. D., et al.
  Udgivet: (2002)
• A 6-Week Oral Toxicity Study of Oral Cholera Vaccine in Sprague-Dawley Rats
  af: Baek, Yeong-Ok, et al.
  Udgivet: (2012)